Supported by science

 Steve Broughton, founder of SafeGroup

Touchpoint Shield™ provides a scientifically rigorous solution and the enhanced reassurance that customers want as the UK emerges from the COVID-19 pandemic, says Steve Broughton, founder of SafeGroup, which is launching the product.

His degree in biology has given him a particular interest in the science behind cleaning and infection control technologies, and his personal research led him to the combined benefits of silver ions and ceramic coatings.

I was excited when I first saw the possibilities. It was like being back in the lab, looking down a microscope and making an important discovery.

I wanted a solution that outperforms transitory disinfection sprays, that’s easy to apply, is always on and gives long-term peace of mind. I believe, with Touchpoint Shield, we’ve found it.

COVID-19 has changed the hygiene landscape. Our customers want better technology and more certainty when dealing with viruses, bacteria and other microbial threats in work environments.

It has to go hand-in-hand with protecting the wellbeing of staff and customers. So they’re happy to return to work and buying spaces, knowing that an organisation has gone to the next level to improve safety. Touchpoint Shield™ does both those things.

We’re aware new technologies need explaining, which is why we’ve put together an extensive FAQ resource to give clear answers to questions about how Touchpoint Shield™ works. If you do not see your question answered, call us here at SafeGroup. We’d be happy to explain more.